TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--The first patients have been dosed in three global, randomized phase 3 trials evaluating the efficacy and safety of datopotamab deruxtecan ...
Microinverter manufacturer Enphase has officially launched a new 208 V three-phase offering. The company said that it is also offering a focused support team and design tools for small business solar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback